On August 31, according to Huadong Pharmaceutical, recently, Hangzhou Sino-US Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Pharmaceutical Co., Ltd., and its strategic partner Heidelberg Pharma Research GmbH, a wholly-owned subsidiary of Heidelberg Pharma AG, officially signed a new additional cooperation agreement. The two sides will focus on joint research and development of next-generation antibody drug conjugates and push the strategic partnership into a new stage.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.